The incidence and epidemiology of plasma cell neoplasms
- PMID: 8520495
The incidence and epidemiology of plasma cell neoplasms
Abstract
Plasma cell neoplasia includes monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), and Waldenström's macroglobulinemia (WM). In MGUS, a large, stable clone does not cause symptoms; additional change(s) is/are required to convert this clone into a progressively expanding tumor that becomes symptomatic, as in MM or WM. The prevalence of MGUS (i.e., the number of cases in a defined population at a certain time) is 20 times greater than MM. The incidence (i.e., the number of cases developing in a defined population in a defined period) has not been determined for MGUS. Between 1960 and 1969, the average, annual, age-adjusted (1950 standard) incidence of MM in Malmö, Sweden was 3.4/10(5). The incidence of MM is strongly influenced by the age and race of the population, and the diagnostic services available. MM is a disease of old age; it rarely occurs before the age of 40. The incidence of MM increases rapidly with age, is lowest among the Chinese and Japanese, intermediate among Caucasians in America and Europe, and highest among blacks in the USA. The striking differences in the incidence of MM in different countries appears to be due to racial rather than environmental differences, since the low incidence among the Chinese and Japanese in Asia has migrated with them to the Bay area of California and to Hawaii. The high incidence of MM in USA black males (10.8/10(5)) and females (7.2/10(5)) is more than twice the rate for whites in the same regions.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.Cancer. 1998 Mar 15;82(6):1078-81. Cancer. 1998. PMID: 9506352
-
Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.Acta Oncol. 2016;55(1):91-8. doi: 10.3109/0284186X.2015.1096019. Epub 2015 Nov 11. Acta Oncol. 2016. PMID: 26559865
-
Malignant transformation in IgM monoclonal gammopathy of undetermined significance.Semin Oncol. 2003 Apr;30(2):178-81. doi: 10.1053/sonc.2003.50067. Semin Oncol. 2003. PMID: 12720132
-
Monoclonal and biclonal immunoglobulin-producing disorders.Eur J Haematol Suppl. 1989;51:11-8. Eur J Haematol Suppl. 1989. PMID: 2697582 Review.
-
Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.Br J Haematol. 2007 Dec;139(5):663-71. doi: 10.1111/j.1365-2141.2007.06845.x. Br J Haematol. 2007. PMID: 18021080 Review.
Cited by
-
Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth.Cancer Res. 2016 Sep 1;76(17):4981-93. doi: 10.1158/0008-5472.CAN-16-0232. Epub 2016 Jun 30. Cancer Res. 2016. PMID: 27364558 Free PMC article.
-
Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study.Cancer Med. 2023 Nov;12(22):20964-20975. doi: 10.1002/cam4.6649. Epub 2023 Nov 1. Cancer Med. 2023. PMID: 37908181 Free PMC article.
-
Clinicopathological characteristics of extremely young Korean multiple myeloma patients: therapeutic implications.Korean J Intern Med. 2017 Jul;32(4):722-730. doi: 10.3904/kjim.2016.256. Epub 2017 Jun 26. Korean J Intern Med. 2017. PMID: 28651310 Free PMC article.
-
The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital.J Clin Diagn Res. 2012 Nov;6(9):1458-61. doi: 10.7860/JCDR/2012/4213.2532. J Clin Diagn Res. 2012. PMID: 23285429 Free PMC article.
-
Syndecan-1: a dynamic regulator of the myeloma microenvironment.Clin Exp Metastasis. 2008;25(2):149-59. doi: 10.1007/s10585-007-9125-3. Epub 2007 Nov 20. Clin Exp Metastasis. 2008. PMID: 18027090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical